unfractionated heparin

unfractionated heparin

n.
Mentioned in ?
References in periodicals archive ?
For the treatment of established venous thromboembolism, LMWH is safe and effective than unfractionated heparin. Moreover, home therapy of DVT with LMWH, compared with inpatient therapy with unfractionated heparin, produces comparably better clinical outcomes and patient satisfaction, with cost savings.
This report on unfractionated heparin market studies the current as well as future prospects of the market globally.
Nakajima et al in a case report suggested that the use of unfractionated heparin is adequate in patients with MTS and interventional options should be reserved for patients with persistent symptoms after the use of anticoagulation.3 We managed our patient with only conservative treatment which showed immediate symptom relief and no evidence of post thrombotic syndrome to date.
CX-01 is a new chemical entity derived from unfractionated heparin with very low anticoagulant activity.
Summary: This report on unfractionated heparin market studies the current as well as future prospects of the market globally.
After the completion of thrombolytic therapy, following recovery to less than twofold the basic value of activated partial thromboplastin time (aPTT), intravenous unfractionated heparin infusion (80 units/kg as a loading dose and then 18 units/kg/h continuous infusion) was started.
The proportion of patients receiving unfractionated heparin versus low-molecular-weight heparin was similar between the two groups, with about 58% treated with unfractionated heparin.
Study patients received one of two types of blood thinners before surgery: subcutaneous enoxaparin, which lowers the activity of clotting proteins in the blood, and unfractionated heparin (UFH), which works with a natural protein in the body to block clot formation.
Background: Unfractionated heparin (UFH), despite its limitations, has been used as the primary anticoagulant alternative during the percutaneous coronary intervention (PCI).
The standard therapy is anticoagulant (unfractionated heparin or low-molecular-weight heparins) administration, but there is still low possibility to need surgery for the complications such as bowel stricture or ischemic bowel disease.
Systematic review and metaanalysis show that treatment with the combination of unfractionated heparin (UFH) and aspirin could reduce the risk of pregnancy loss (relative risk, 0.46; 95% CI, 0.29 - 0.71) compared to aspirin alone, although the level of evidence was modest.